* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Anti Epileptic Drugs
Discovery and development of antiandrogens wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Toxicodynamics wikipedia , lookup
Pharmacognosy wikipedia , lookup
Drug discovery wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Plateau principle wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Drug design wikipedia , lookup
Prescription costs wikipedia , lookup
Psychopharmacology wikipedia , lookup
Drug interaction wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Dydrogesterone wikipedia , lookup
Neuropharmacology wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Anti Epileptic Drugs Prof S Kalyanaraman OXCARBAZEPINE OXCARBAZEPINE 1. What is the mechanism of action? Blocks voltage dependant sodium channel OXCARBAZEPINE 2. Describe the pharmacokinetics • Bioavailability < 100 % • Reduced in liver to the active metabolite, monohydroxy derivative (MHD) • 27 % excreted unchanged by kidneys • Peak serum drug level 4 – 6 hours • Peak serum metabolite level 8 hours • Elimination half life 8 – 10 hours • Time to steady state – 2 days • Protein binding 38 % OXCARBAZEPINE 3. What are the indications ? • Partial seizures in adults • All indications of Carbamazepine including diabetic neuropathy • Trigeminal neuralgia • Mood stabiliser in affective disorders OXCARBAZEPINE 4. What are the contraindications ? • • • • Hypersensitivity to Carbamazepine Pregnancy, Lactation Renal dysfunction, hepatic dysfunction Hyponatremia (25 – 50 % of patients on chronic therapy have Na levels below 135 but this is usually asymptomatic. Hyponatremia is due to anti diuretic effect and consumption of large volumes of fluid is to be discouraged) (Serum sodium level should be monitored regularly during therapy) OXCARBAZEPINE 5. What are the side effects ? Hyponatremia Drowsiness Dizziness Ataxia Diplopia Dry mouth Dyspepsia Abdominal pain Nausea Vomiting Constipation Weight gain Diarrhea Alopecia Fatigue Tremor Skin rash OXCARBAZEPINE 6. What is the dosage? • Starting dose 300 mg bd • Increase dose by 600 mg / day at weekly intervals • Maximum 1200 mg bd • Dosing interval twice daily OXCARBAZEPINE 7. What is the cost ? 150 mg Rs 3 / - 300 mg Rs 5 / - 600 mg Rs 10 / - OXCARBAZEPINE 8. Name some proprietary preparations. • • • • • • • • Oxep (Nicholas Piramal) Oxrate (Merind Pharma) Oxetal (Sun Pharma) Oxeptal (Stedman) Oxcarb (Cipla) Selzic (Solus Pharma) Zenoxa (Intas) Trioptal (Novartis) OXCARBAZEPINE 9. What are the advantages ? • • • • Better than Carbamazepine Milder side effects Fewer idiosyncratic reactions Fewer interactions with other drugs OXCARBAZEPINE 10. What are the disadvantages ? • Moderately high cost • May render hormonal contraceptive ineffective • May increase plasma level of Phenytoin and Phenobarbitone and these drugs may decrease oxcarbazepine level CLONAZEPAM CLONAZEPAM 1. What is the mechanism of action ? • It is a benzodiazepine • GABA – A receptor agonist CLONAZEPAM 2. What is the pharmacokinetics ? • • • • Oral bioavailability – 80 % Time to peak levels – 1 – 8 hours Time to steady state – 4 – 10 days Biotransformation • Reduction, Hydroxylation, Acetylation, Nitration in liver • Elimination half life – 20 – 80 hours • Protein binding – 86 % • Active metabolite - none CLONAZEPAM 3. What are the indications ? • Partial seizures, simple and complex • GTCS • Atonic seizures • Absence seizures • Myoclonic seizures • Lennox Gastaut Syndrome • Infantile spasms • Neonatal seizures • • • • • • • Drug induced dyskinesia Anxiety Panic attacks Bipolar affective disorder Multifocal tics Neuralgias Hypokinetic Dysarthria in Parkinsonism CLONAZEPAM 4. What are the contraindications ? • Pregnancy • Lactation • Hepatic dysfunction • Pulmonary insufficiency • Sleep apnea • Respiratory depression Renal dysfunction (can be used with caution) CLONAZEPAM 5. What are the side effects ? Sedation Dizziness Forgetfulness Drowsiness Short attention span Hypersalivation Hyperactivity Unsteadiness Restlessness Aggressiveness LEUCOPENIA Personality changes Behavioral changes Psychosis CLONAZEPAM 6. What are the drug interactions ? Nil significant CLONAZEPAM 7. What is the dose, available formulations and cost ? • Start with 0.25 mg hs. Can go upto 2 mg bd • 0.5 mg Rs 1.5/• 1 mg Rs 2/• 2 mg Rs 3/- CLONAZEPAM 8. What are the available market preparations ? Clonotril Epitril Lona Lonazep Melzap Petril Rivotril Sezolep Zee (Torrent) (Novartis) (Triton) (Sun) (Pentacare) (Micro Labs) (Nicholas) (Merind) (Sali – Mano) CLONAZEPAM 9. What are the main advantages ? Wide spectrum of activity including many childhood epilepsy syndromes CLONAZEPAM 10. What are the main disadvantages ? • Sedation • Probable teratogenecity • Withdrawal symptoms – Sudden withdrawal – may even lead to status – Moderately slow withdrawal • Increased seizure frequency • Anxiety, Insomnia, Restlessness, Confusion – Withdrawal rate should not exceed 0.5 mg per month LAMOTRIGINE LAMOTRIGINE 1. What is the mechanism of action ? • Inhibits release of excitatory aminoacids especially glutamate • Blocks voltage dependant sodium channel conductance LAMOTRIGINE 2. What is the pharmacokinetics ? • • • • • • • • • • Bioavailability 98 % Oral dose rapidly and completely absorbed Peak serum level 1 – 3 hours (adults) and 1 – 6 hours (children) Plasma half life 12 – 60 hours Time to steady state 3 – 15 days Protein binding 55 % 85 % metabolised by conjugation in liver and excreted as glucuronide Active metabiolite – none 10 % excreted by kidneys unchanged Eliminated more rapidly in patients on hepatic enzyme inducing drugs like phenytoin, phenobarbitone and carbamazepine LAMOTRIGINE 3. What is the dosage ? • • • • Starting dose 12.5 to 25 mg / day Increase dose by 50 mg every 1 – 2 weeks Maintenance dose 200 – 500 mg / day in 2 divided doses Clearance of lamotrigine is reduced by 50 % in presence of valproate – so dose in patient already getting valproate – – – – 25 mg on alternate days for 2 weeks Then 25 mg / day for 2 weeks Increase by 25 mg / day every 1 – 2 weeks Maximum dose 75 mg bd • Dose reduction should be 50 % per week over 2 – 3 weeks unless safety concerns require rapid withdrawal LAMOTRIGINE 4. What are the indications ? • • • • • • • Preferably II line drug, rarely I line drug Partial seizures } adults Secondary generalised seizures } Absences Atonic seizures Lennox Gastaut Syndrome Drug may increase frequency of myoclonic seizures LAMOTRIGINE 5. What are the side effects ? • Rash especially if valproate is also given, if starting dose is high or if dose escalation is rapid (Rash may disappear despite continued medication) • Headache, fever, arthralgia, asthenia • Tremor, eosinophilia, blood dyscrasias, Steven Johnson syndrome • Nausea, dyspepsia, vomiting • Confusion, agitation, hallucination, psychosis • Insomnia, drowsiness • Blurred vision, diplopia • Rhinitis, pharyngitis, bronchitis, cough • Hepatic dysfunction • Unsteadiness especially if carbamazepine is also given LAMOTRIGINE 6. What are the contraindications ? • Lactation – as considerable amount is excreted in milk and elimination in infants is slow • Special caution in • Renal dysfunction • Hepatic dysfunction • Concomitant valproate therapy (a few cases have been reported when patients who had sexual dysfunction while on AED improved with Lamotrigine) LAMOTRIGINE 7. Formulations, Cost, Brand names ? 25, 50, 100 mg • • • • • • Lamitor (Torrent) Lamepil (Innova) Lamidus (Zydus) Lametec (Cipla) Lamez (Intaz) Lamosyn (Sun) 100 mg Rs 10 / - TOPIRAMATE TOPIRAMATE 1. What is the mechanism of action ? • Multiple actions contributing to its antiepileptic potential • Actions on sodium conductance, GABA - A receptor activity, glutamate receptor activity, calcium channel activity and carbonic anhydrase TOPIRAMATE 2. What is the pharmacokinetics ? • • • • • • Bioavailability 100 % Plasma elimination half life 18 – 30 hours Time to steady state 4 – 5 days Protein binding 15 % 80 % drug eliminated unchanged in urine Rest metabolised to inactive compounds in liver TOPIRAMATE 3. Any interactions with other drugs ? • Topiramate levels decreased by concomitant administration of carbamazepine, phenytoin and phenobarbital • Phenytoin level increased by topiramate TOPIRAMATE 4. What is the dosage ? • Start with 25 mg / day • Increase dose by 25 – 50 mg every fortnight • Maximum dose 200 mg bd (rarely 300 mg bd) TOPIRAMATE 5. What are the indications ? • Second line drug for – – – – – Partial seizures Secondary generalised seizures GTCS Atonic seizures Lennox Gastaut syndrome • Second line drug for – Migraine – Trigeminal neuralgia TOPIRAMATE 6. What are the contraindications ? • • • • Renal dysfunction History of presence of renal calculi Pregnancy Glaucoma (ensure adequate fluid intake to decrease risk of renal calculi) TOPIRAMATE 7. What are the side effects ? • Confusion, impaired concentration, memory difficulty, mental slowing, word finding difficulty • Fatigue, somnolence, headache • Agitation, emotional lability, depression, paresthesiae • Anorexia, nausea, diarrhea, weight loss • Leucopenia • Nystagmus, ataxia, diplopia, tremor • Renal stones • Adverse effects reduced by slow titration of drug TOPIRAMATE 8. Formulations, Cost, Brands ? 25, 50, 100 mg • • • • • • • Epitome (Triton) Topiram (Zydus) Topaz (Intaz) Topiral (Symbiosis) Topirate (Stimulus) Topamate (Cipla) Nextop (Torrent) 100 mg Rs 14 / - TOPIRAMATE 9. What are the main advantages ? • Weight loss (especially when valproate causes weight gain) • Powerful antiepileptic effect, sometimes effective when all other AED’s are ineffective TOPIRAMATE 10. What are the main disadvantages ? • Cost • Weight loss • Side effects ZONISAMIDE ZONISAMIDE 1. How is it different from other AEDs ? It is a sulfonamide derivative chemically distinct from others ZONISAMIDE 2. What is the mechanism of action ? Multiple – – – – Inhibits voltage gated sodium channel Affects T type calcium currents Affects excitatory glutaminergic transmission Binds to benzodiazepine GABA – A receptor ZONISAMIDE 3. What are the indications ? • • • • • • Partial seizures Generalised seizures Lennox Gastaut Syndrome Infantile spasm Atypical absences Progressive myoclonic epilepsy (Licenced for monotherapy and adjunct therapy in Japan Licenced for adjunct therapy in refractory partial epilepsy only in USA, UK and Europe) ZONISAMIDE 4. What are the formulations and brands ? 25, 50 and 100 mg capsules Zonisep (Synergy) Zonimide ZONISAMIDE 5. What is the pharmacokinetics ? • • • • • Oral bioavailability < 100 % Time to peak levels 2 – 4 hours Elimination half life 50 – 70 hours Protein binding 30 – 60 % Biotransformation: Acetylation, Reduction, Glucuronidation • Active metabolite - none ZONISAMIDE 6. What are the drug interactions ? Half life of zonisamide reduced by phenytoin to 45 % carbamazepine to 65 % phenobarbitone to 65 % valproate to 75 % ZONISAMIDE 7. What is the dosage ? • Adults: – Initial 25 mg bd – Maintenance 100 – 400 / day – Maximum 600 mg / day • Children: – Initial 2 – 4 mg / kg / day – Maintenance 4 – 8 mg / kg / day • Dosing interval: – 1 – 2 times / day • Half life is long on monotherapy but considerably reduced in adjunctive therapy ZONISAMIDE 8. What are the side effects ? Impaired concentration Mental slowing Insomnia Drowsiness Fatigue Irritability depression Ataxia Dizziness Diplopia Nausea Vomiting Anorexia Weight loss Renal calculi Abdominal pain Skin rashes Itching Oligohydrosis Risk of heat stroke especially in infants and young children ZONISAMIDE 9. What are the contraindications ? • Renal failure • Pregnancy • Lactation ZONISAMIDE 10. What are the main advantages ? • Broad spectrum of action • Specially useful in Lennox Gastaut syndrome, infantile spasms, progressive myoclonic epilepsy ZONISAMIDE 11. What are the main disadvantages ? • Side effects